Role of S100 Proteins in Colorectal Carcinogenesis

The family of S100 proteins represents 25 relatively small (9–13 kD) calcium binding proteins. These proteins possess a broad spectrum of important intracellular and extracellular functions. Colorectal cancer is the third most common cancer in men (after lung and prostate cancer) and the second most frequent cancer in women (after breast cancer) worldwide. S100 proteins are involved in the colorectal carcinogenesis through different mechanisms: they enable proliferation, invasion, and migration of the tumour cells; furthermore, S100 proteins increase angiogenesis and activate NF-κβ signaling pathway, which plays a key role in the molecular pathogenesis especially of colitis-associated carcinoma. The expression of S100 proteins in the cancerous tissue and serum levels of S100 proteins might be used as a precise diagnostic and prognostic marker in patients with suspected or already diagnosed colorectal neoplasia. Possibly, in the future, S100 proteins will be a therapeutic target for tailored anticancer therapy

Analysis of cross sections on iron and oxygen using Cf-252 neutron source

The leakage neutron spectra measurements have been done on benchmark spherical assemblies with Cf-252 source in center of 1) heavy water sphere with diameter of 30 cm (with Cd cover) and of 2) iron spheres with diameter of 100 cm and 50 cm. It has been stated for years that transport calculations by iron overestimate measured spectra in energy region around 300 keV by about 20-40 % (calculation to measurement ratio C/E = 1.2-1.4). The influence of an artificial changes in cross-section XS-Fe-56 (n,elastic)designed by IAEA, Nuclear Data Section, has been studied on the iron spheres. Influence of those XS-corrections to calculated neutron spectrum is presented

Use of nickel sphere and copper cube with

The leakage neutron spectrum measurements have been done on benchmark spherical assembly-nickel sphere with a diameter of 50 cm and a copper cube (block) with dimensions of 49.5 x 49.5 x 48 cm3 in Research Centre Rez (RC Rez). The 252Cf neutron source was placed into the centre of nickel sphere and copper cube. The proton recoil method was used for the neutron spectrum measurement using spherical hydrogen proportional detectors (HPD) with pressure of 400 and 1000 kPa (diameter of detectors is 4 cm) and scintillation stilbene (ST) detector (diam. of 1 x 1 cm). The neutron energy range of spectrometer is from 0.04 MeV to 1.3 MeV for HPD and from 1 MeV to 12 MeV for ST. The adequate MCNP neutron spectrum calculations based on data libraries ENDF/B-VII.1, ENDF/B-VIII.0, JEFF-3.3, BROND-3.1 were done and compared with the experiment, i.e., calculation to experiment ratio C/E was determined

Neutron spectra measurement and calculations using data libraries CIELO, JEFF-3.2 and ENDF/B-VII.1 in iron benchmark assemblies

The leakage neutron spectra measurements have been done on benchmark spherical assemblies - iron spheres with diameter of 20, 30, 50 and 100 cm. The Cf-252 neutron source was placed into the centre of iron sphere. The proton recoil method was used for neutron spectra measurement using spherical hydrogen proportional counters with diameter of 4 cm and with pressure of 400 and 1000 kPa. The neutron energy range of spectrometer is from 0.1 to 1.3 MeV. This energy interval represents about 85 % of all leakage neutrons from Fe sphere of diameter 50 cm and about of 74% for Fe sphere of diameter 100 cm. The adequate MCNP neutron spectra calculations based on data libraries CIELO, JEFF-3.2 and ENDF/B-VII.1 were done. Two calculations were done with CIELO library. The first one used data for all Fe-isotopes from CIELO and the second one (CIELO-56) used only Fe-56 data from CIELO and data for other Fe isotopes were from ENDF/B-VII.1. The energy structure used for calculations and measurements was 40 gpd (groups per decade) and 200 gpd. Structure 200 gpd represents lethargy step about of 1%. This relatively fine energy structure enables to analyze the Fe resonance neutron energy structure. The evaluated cross section data of Fe were validated on comparisons between the calculated and experimental spectra

Small intestinal bacterial overgrowth syndrome

Human intestinal microbiota create a complex polymicrobial ecology. This is characterised by its high population density, wide diversity and complexity of interaction. Any dysbalance of this complex intestinal microbiome, both qualitative and quantitative, might have serious health consequence for a macro-organism, including small intestinal bacterial overgrowth syndrome (SIBO). SIBO is defined as an increase in the number and/or alteration in the type of bacteria in the upper gastrointestinal tract. There are several endogenous defence mechanisms for preventing bacterial overgrowth: gastric acid secretion, intestinal motility, intact ileo-caecal valve, immunoglobulins within intestinal secretion and bacteriostatic properties of pancreatic and biliary secretion. Aetiology of SIBO is usually complex, associated with disorders of protective antibacterial mechanisms (e.g. achlorhydria, pancreatic exocrine insufficiency, immunodeficiency syndromes), anatomical abnormalities (e.g. small intestinal obstruction, diverticula, fistulae, surgical blind loop, previous ileo-caecal resections) and/or motility disorders (e.g. scleroderma, autonomic neuropathy in diabetes mellitus, post-radiation enteropathy, small intestinal pseudo-obstruction). In some patients more than one factor may be involved. Symptoms related to SIBO are bloating, diarrhoea, malabsorption, weight loss and malnutrition. The gold standard for diagnosing SIBO is still microbial investigation of jejunal aspirates. Non-invasive hydrogen and methane breath tests are most commonly used for the diagnosis of SIBO using glucose or lactulose. Therapy for SIBO must be complex, addressing all causes, symptoms and complications, and fully individualised. It should include treatment of the underlying disease, nutritional support and cyclical gastro-intestinal selective antibiotics. Prognosis is usually serious, determined mostly by the underlying disease that led to SIBO

Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle

AIM: To evaluate bacteriocinogeny in short-term high-dose indomethacin administration with or without probiotic Escherichia coli Nissle 1917 (EcN) in experimental pigs